Dear MTCONS, You are cordially invited to attend the May 1, 2025 Chapter meeting at Char Restaurant.
The Topic is:
TECVAYLI® Overview & DARZALEX FASPRO® PERSEUS Trial:
(Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Vrd Alone in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Eligible for ASCT: Primary Results of the Perseus Trial)
SPEAKER:
Nicholas Barkemeyer, PA
Physicians Assistant
Tennessee Oncology, Nashville, TN
DATE/TIME
Thursday, May 1, 2025
5:30 PM – Registration
6:00 PM – Chapter Meeting and Presentation
VENUE;
Char Restaurant
3988 Hillsboro Pike,
Nashville, Tennessee 37215
Valet Parking will be validated
